Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...
Lung cancer is the third most common cancer and the leading cause of cancer-related deaths in the U.S., and according to the ...
The FDA has approved the drug durvalumab for adults with limited-stage small-cell lung cancer (LS-SCLC) whose disease hasn’t ...
Austin American-Statesman on MSN4h
Lung cancer as a nonsmoker younger than 40? Yes, as Central Texas woman found out.While lung cancer is most common in men ages 75 and older who were smokers, about 10% of all cases are in people younger than ...
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with ...
The Food and Drug Administration (FDA) has approved Imfinzi ® (durvalumab), as a single agent, for the treatment of adult patients with limited-stage small cell lung cancer (LS-SCLC) whose disease has ...
The approval of durvalumab, based on data from the phase 3 ADRIATIC study, offers a new standard of care for patients with ...
News Medical on MSN6d
PROSPECT-Lung trial aims to improve treatment for patients with resectable non-small cell lung cancerThe highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
HealthDay on MSN9d
Lung Cancer: What It Is, Types, Symptoms & TreatmentGetting a diagnosis of lung cancer can be scary, especially when you don't know what to expect. To help, experts will guide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback